Who: Department of Bioengineering, University of Pittsburgh and College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology.
What: Localised delivery of drug payloads to target tissues allows effective drug dosing while reducing the side effects of systemic drug delivery using graphene oxide nanocomposites. See “Electrically Controlled Drug Delivery from Graphene Oxide Nanocomposite Films”
Where: On-demand drug delivery. The unique properties of nanomaterials when combined with special high loading and controlled release provide superior performance for drugs.
When: Compliance with international regulatory industrial and healthcare guidelines before commercialization and translational medicine can take over 10 years and the cost of producing a new drug can be upwards of $800 million.
